Early Predictive Biomarkers for Hypertension Using Human FetalAstrocytes
DOI:
https://doi.org/10.47363/JVMS/2024(2)109Keywords:
Hypertension, Astrocytes, Biomarkers, Glial Fibrillary Acidic Protein (GFAP), Proteomics, Confocal MicroscopyAbstract
Background: Hypertension (HTN) is a major risk factor for Cerebrovascular and cardiovascular diseases, causing premature deaths. Hence, there is an
urgent need for predictive biomarkers to detect HTN before its onset.
Methods
• Cell Culture Technique: Growth of HFAs, followed by conversion of normal (A2) HFAs intoreactive (A1) type, by using ATP solution.
• Confocal Microscopy: Quantification of Glial Fibrillary Acidic Protein (GFAP) in A1 and A2 HFAs, by using antibody ab 7260 with AF 488.
Proteomics Methos
• Extraction of proteins from A1 and A2 HFAs, using Single-pot, Solid-phase-enhanced Sample Preparation (SP3) protocol.
• Liquid Chromatography- Mass Spectrometry techniques for obtaining the lev-els of calcium-gated proteins in A1 and A2 cell-solutions.
Results
• Micrographs obtained by Leica Microsystem indicated thicker filaments in A1 HFAs compared to A2 HFAs.
• Confocal results showed higher levels of GFAP in A1 HFAs (P> 0.05).
• Proteomics data analysed by PEAKS software revealed that proteins, such as GFAP were higher in reactive HFAs.
Conclusions: The results showed higher levels of GFAP in A1 HFAs. Therefore, early detection of GFAP in human body fluids could be a reliable predictive
biomarker for HTN.